  Cell-based models provide a helpful approach for simulating complex systems
that exhibit adaptive, resilient qualities, such as cancer. Their focus on
individual cell interactions makes them a particularly appropriate strategy to
study the effects of cancer therapies, which often are designed to disrupt
single-cell dynamics. In this work, we also propose them as viable methods for
studying the time evolution of cancer imaging biomarkers (IBM). We propose a
cellular automata model for tumor growth and three different therapies:
chemotherapy, radiotherapy, and immunotherapy, following well-established
modeling procedures documented in the literature. The model generates a
sequence of tumor images, from which time series of two biomarkers: entropy and
fractal dimension, is obtained. Our model shows that the fractal dimension
increased faster at the onset of cancer cell dissemination, while entropy was
more responsive to changes induced in the tumor by the different therapy
modalities. These observations suggest that the predictive value of the
proposed biomarkers could vary considerably with time. Thus, it is important to
assess their use at different stages of cancer and for different imaging
modalities. Another observation derived from the results was that both
biomarkers varied slowly when the applied therapy attacked cancer cells in a
scattered fashion along the automatons' area, leaving multiple independent
clusters of cells at the end of the treatment. Thus, patterns of change of
simulated biomarkers time series could reflect on essential qualities of the
spatial action of a given cancer intervention.
